3/22/2023

Timolol Ophthalmic Gel Forming Solution

Products Affected - Description

- Timoptic-XE ophthalmic solution, Bausch Health, 0.25%, 5 mL bottle, 1 count, NDC 24208-0814-25
- Timoptic-XE ophthalmic solution, Bausch Health, 0.5%, 5 mL bottle, 1 count, NDC 24208-0816-25

Reason for the Shortage

- Alembic has timolol ophthalmic gel forming solution available.
- Bausch Health has Timoptic-XE ophthalmic gel forming solution on shortage due to manufacturing delays. The company discontinued timolol ophthalmic gel forming solution in September 2020.
- Sandoz did not provide a reason for the shortage.

Available Products

- Timolol ophthalmic solution, Alembic, 0.25%, 5 mL bottle, 1 count, NDC 62332-0545-05
- Timolol ophthalmic solution, Alembic, 0.5%, 5 mL bottle, 1 count, NDC 62332-0546-05
- Timolol ophthalmic solution, Sandoz, 0.25%, 5 mL bottle, 1 count, NDC 61314-0224-05
- Timolol ophthalmic solution, Sandoz, 0.5%, 5 mL bottle, 1 count, NDC 61314-0225-05

Estimated Resupply Dates

- Bausch Health has Timoptic-XE 0.25% and 0.5% 5 mL bottles on back order and the company cannot estimate a release date.

Updated

Updated March 22, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 11, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.